For the full year,net loss reported to Rs 0.31 crore in the year ended March 2025 as against net loss of Rs 0.69 crore during the previous year ended March 2024. There were no Sales reported in the ...

This fast-moving altcoin priced under $0.05 is outperforming several top cryptocurrencies in early-stage growth metrics.

Treat infection if present; discontinue if infection persists or worsens. Do not use near eyes, or on diaper dermatitis or pre-existing skin atrophy. Avoid abrupt cessation in chronic use.

Each quarter, the Board of Trustees reviews the amount of any potential distribution from the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor ...

For the full year,net profit declined 19.48% to Rs 0.62 crore in the year ended March 2025 as against Rs 0.77 crore during the previous year ended March 2024. Sales rose 51.60% to Rs 229.68 crore in ...